Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetaminophen + Phenylephrine is an approved, orally administered small molecule combination drug. It contains two active ingredients: acetaminophen (paracetamol), an analgesic and antipyretic that works centrally to reduce pain and fever, and phenylephrine, a sympathomimetic decongestant that acts as an alpha-1 adrenergic receptor agonist to relieve nasal and sinus congestion. Together, the combination is used to treat symptoms associated with the common cold, flu, and upper respiratory conditions, including pain, fever, and nasal congestion. The drug is typically administered in tablet form and is widely available as a generic formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + phenylephrine.